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Abstract.  The retinoblastoma (RB) protein is present 
at low levels in early mouse embryos and in pluripo- 
tent P19 embryonal carcinoma cells; however, the lev- 
els of RB rise dramatically in neuroectoderm formed 
both in embryos and in differentiating cultures of P19 
cells. To investigate the effect of inactivating RB and 
related proteins p107  and p130,  we transfected P19 
cells with genes encoding mutated versions of the 
adenovirus E1A protein that bind RB and related pro- 
teins. When these E1A-expressing P19 cells were in- 
duced to differentiate into neuroectoderm, there was a 
striking rise in the expression of c-fos and extensive 
cell death. The ultrastructural and biochemical charac- 
teristics of the dying cells were indicative of apoptosis. 
The dying cells were those committed to the neural 
lineages because neurons and astrocytes were lost from 
differentiating cultures. Cell death was dependent on 
the ability of the E1A protein to bind RB and related 
proteins.  Our results suggest that proteins of the RB 
family are essential for the development of the neural 
lineages and that the absence of functional RB activity 
triggers apoptosis of differentiating neuroectodermal 
cells. 
HE retinoblastoma (RB) ~  protein is thought to play a 
ey role in the regulation of  cell growth and differentia- 
.&.  tion (reviewed in 27, 30, 48). A role for RB in the con- 
trol of cell proliferation is indicated by the observations that 
the loss of functional RB occurs in many human tumors 
(reviewed in 66), that injection of RB into proliferating cells 
induces  their  arrest  in  G1  phase  (25),  that  RB  is  phos- 
phorylated in a  cell cycle-dependent manner (reviewed in 
12), and that oncogenic proteins such as SV40 T antigen and 
adenovirus E1A proteins bind to RB and this binding is es- 
sential for their oncogenicity (8, 50). 
A role for RB in differentiation is suggested by a number 
of observations. Mice carrying homozygous Rb mutations 
die in utero at E15-16 suffering from severe haematopoietic 
and neurogenic defects (10, 34, 40). The absence of RB did 
not seem to adversely affect the cell cycle; rather, the em- 
bryos  appeared  to  die  because  erythrocytes  and  neural 
tissues failed to mature. In addition, RB and related pro- 
teins appear essential for the maturation of skeletal muscle 
(26, 55). 
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We set out to examine the role of  the Rb gene family during 
neuronal differentiation using cultures of P19 embryonal car- 
cinoma cells. When treated with retinoic acid (RA) these 
cells differentiate into cultures primarily consisting of neu- 
rons and astrocytes (35,  36).  During this neuroectodermal 
differentiation we  found that the level  of the RB protein 
rose dramatically from barely detectable levels in the un- 
differentiated cells  (58).  To determine if this  rise  in  RB 
level is required for neural differentiation we set out to use 
E1A to functionally inactivate RB and related proteins. The 
adenovirus E1A oncogene encodes a multifunctional nuclear 
protein (reviewed  in  17) that binds to RB and related pro- 
teins, p107 and p130. The binding of E1A to this family of 
related proteins prevents the interaction of these proteins 
with transcription factors E2F and DP-1 (3, 4).  Thus E1A 
provides a useful perturbant with which to examine the roles 
of RB family members in regulating cell differentiation. 
The expression of wild-type E1A in undifferentiated P19 
cells resulted in drastic morphological changes (46, 59, 64, 
65);  however,  these effects of E1A were dependent on the 
binding of E1A to p300,  a cellular protein unrelated to RB 
(19). We were able to establish clones of P19 cells expressing 
E1A mutants unable to bind p300 but which retained the ca- 
pacity to bind pRB, p107 and p130. We report that differen- 
tiating  P19  cells  expressing  these  E1A  proteins  undergo 
apoptosis in those cells that become committed to form neu- 
rons and astrocytes. 
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Expression Plasmids 
All expression vectors were based on the regulatory sequences of  the mouse 
phosphoglycerate kinase (Pgk-1) gene promoter (1, 44). Plasmids contain- 
ing EtA coding regions and various deletion mutants were kindly provided 
by Dr. S. Bayley (McMaster University, Hamilton, Ontario) (Jelmsa et al., 
1988) and Dr. P. Branton (McGill University, Montreal, Quebec) (5). Dele- 
tion mutants defective in the binding of p300 (see Fig. 1 A) are as follows 
(amino acid deletions shown in parentheses): 1101 (4-25);  1104 (48-60); 
and 1141 (61-69). The double-deletion  mutant, unable to bindp300 or pRB, 
p107 and p130  was  1101-1108 (4-25  and  124-127).  All deletion mutants 
transcribe only the 12S mRNA. The ELA-coding regions were excised by 
digestion with AfllII and HincU, and ligated into a vector containing the 
Pgk-I promoter and 3' regulatory sequences (44). The Pgk-1 promoter was 
also used for expression constructs conferring puromycin resistance (Pgk- 
puro). A plasmid, B17, containing the Pgk-1 promoter and the first 17 kb 
of the mouse Pgk-1 genomic clone, was routinely cotransfected to enhance 
incorporation when stable transformants were generated (45). 
Cell Culture and Transfections 
P19 cells were maintained in ¢-MEM containing 5% calf serum and 5% 
FCS and induced to differentiate as described (52). 
DNA was introduced into cells by calcium phosphate precipitation (9). 
Stable transformants were made by the eotransfection of 10 ttg of the EtA 
carrying plasmid, together with 5/xg of B17 (45), and 2 tLg Pgk-puro. Pu- 
romycin resistant clones were selected by plating ceils in 2/~g/mi puro- 
mycin. After 5-7 d of selection, puromycin resistant colonies were screened 
for EtA expression by immunofluorescence staining with the M73 antibody 
to EtA (28). Stable cell lines were established expressing the EtA mutants, 
1101, 1104,  1141, and the double mutant, 1101/1108. The expression of the 
transfected DNA in stable clones was verified by western blotting with the 
M73 antibody (28). 
Western Blotting 
Western blots and protein extraction were performed as previously described 
(58).  EtA and all deletion mutants were readily detected with a  mouse 
monoclonal antibody (M73) diluted 1:1,000 (28). The rat monoclonal anti- 
body (TROMA-1)  detected cytokeratin 55  (38). A  rabbit polyclonal anti- 
NF160,  diluted at 1:2,000,  was kindly provided by Dr. W. Mushinski (Me- 
Gill  University,  Montreal,  Quebec).  The  mouse  monoclonal  antibody 
directed against p53, diluted at 1:10, was purchased from Oneogene Science 
(Cambridge MA).  Anti-GFAP was  a  mouse monoclonal antibody pur- 
chased from Chemieon International Inc. (Temecula, CA). The secondary 
antibodies were a goat anti-mouse horseradish peroxidase (no.  172-1011; 
Biorad, Mississauga, Ontario) diluted 1:5,000 and a rabbit anti-rat alkaline 
phosphatase (DAKOPATTS, Copenhagen, Denmark). The blots were devel- 
oped by the ECL chemiluminescence system (Amersham, Oakville,  On- 
tario) or the alkaline phosphatase substrate package obtained from GIBCO 
BRL (Galthersburg, MD). 
Isolation of  Fragmented DNA 
To examine DNA fragmentation, 106 cells were seeded on a  100-mm dish 
and treated as described in figure legends. After 48 h cells were subcultured 
at a density of 3  x  106 in the same medium. The next day, cells were har- 
vested, washed once with PBS, and used for DNA isolation  (49).  1.2 ml of 
lysis buffer was added to 5  x  106 cells suspended in 100/~1 of TE buffer 
(10 mM Tris-HCl, pH 8.0, and 1 mM EDTA).  Lysis was allowed to proceed 
at room temperature for 15 min and the mixture centrifuged for 15 min at 
12,000 rpm. The gelatinous pellet was removed with a pipet and the super- 
natant digested with 100 ~tg/ml RNase A at 37°C for 30 min. This was fol- 
lowed by a Proteinase K digestion at 100 t~g/ml, 50°C for 30 min. The DNA 
was then precipitated by adding an equal volume of 100% ethanol and NaC1 
such that the final concentration was 0.5 M.  Following centrifugation the 
pellet was washed with 70% ethanol and resuspended in 50 ttl of TE buffer. 
DNA ladders could be visualized by running 25 ~tl on a 1% agarose gel using 
a  1-kb ladder as a standard. 
Northern Blot Analysis 
Total  RNA was prepared from cells by the lithium/urea method (2).  For 
northern blots ~howing  differentiation time courses, RNA was collected 
from cells for up to 4 d after RA treatment. Due to the high proportion of 
dying cells in some cultures there was insufficient material to provide an 
RNA sample after this time. Time courses with control PI9 cells often in- 
cluded RNA samples for up to 10 d after RA treatment to provide a com- 
plete expression pattern during normal differentiation. 10-t~g aliquots of 
RNA were separated through a  1.0% agarose gel containing 20 mM 3-(N- 
morpholino)propane-suifonic acid,  1 mM EDTA,  5 mM sodium acetate, 
pH 7.0, and 10%  formaldehyde. The RNA was transferred to Hybond-N 
membranes (Amersham) that were then treated with ultraviolet light at 120 
mJ  with  a  GS  Gene  linker  UV  chamber  (Biorad).  Hybridizations  to 
random-primed 3ZP-labeled DNAs, and high stringency washes were per- 
formed as described (Maniatis et al., 1982).  Signals were visualized by au- 
toradiograpby. To strip filters before rehybridization, they were washed for 
2 h at 65°C in a buffer containing 0.005  M  Tris-HCL (pH 8.0), 0.002  M 
NazEDTA  and 0.1×  Denhardt's solution. 
The eDNA probes for c-jun (39), c-myc, and c-fos (63), E2F (37), DP-1 
(24), myoD (14),  and aetin (53) were excised from their plasmid vectors 
before labeling. The munc-18 probe (56)  was a  gift from S. Beushausen 
(NINDS, Bethesda, MD). The probes for cyclins DI, 2, and 3 were excised 
from a pGEM 7ZF vector by digestion with EcoRI-BamH1. 
Electron Microscopy 
P19 and P19[1104]  cultures were exposed to RA for 0, 3, or 7 d and then 
fixed in 1.25% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for 2 h. 
After initial fixation samples were washed three times in 0.1 M sodium caco- 
dylate buffer,  for 15 rain each wash. Samples were postfixed on ice in 1% 
osmium tetroxide for 90 min, dehydrated in ascending concentrations of 
ethanol and acetone, and embedded in Epon-Araldite. Semithin sections 
were stained with toluidine blue for light-microscopic examination. Thin 
sections were cut, stained with uranyl acetate and lead citrate, and examined 
with a Hitachi H-7100 transmission electron microscope. 
Results 
P19 Cells Expressing E1A Undergo  Apoptosis when 
Induced to Differentiate with RA 
We have previously established clones of P19 cells express- 
ing high levels of mutant EtA proteins rendered incapable of 
binding p300 by deletions affecting either the EtA NH2 ter- 
minus or CR1 region (Fig.  1 A). P19 cells expressing such 
EtA mutants were indistinguishable from the parental cells; 
they  proliferated  at  similar  rates  and  expressed  markers 
of undifferentiated embryonal carcinoma cells (59).  When 
treated with RA, P19 cells normally differentiate into neu- 
roectodermal cells  including  neurons  and  astrocytes (35, 
36). RA-treated P19 cells expressing any one of the EtA pro- 
teins encoded by genes  1101, 1104,  or  1141 behaved very 
differently. For example, P19[1104]  cells, which express the 
EtA  protein  encoded  by  the  1104  mutant,  continued  to 
proliferate for 48 h in RA after which the cell number in the 
cultures declined (Fig. 1 B). Widespread cell death was evi- 
dent by  3-4  d.  None of the  surviving  ceils  had  neuritic 
processes but some cells did survive RA treatment and con- 
tinued to proliferate. 
To determine if the cell death observed was due to apop- 
tosis,  DNA  was  isolated from the cultures of RA-treated 
P19[1104]  cells and was found to be fragmented into mul- 
timers of nucleosome size 3-4 d  after initial exposure to 
RA  (Fig.  2  A).  No DNA ladder was evident in untreated 
P19[1104]  cells or  from the parental P19 cells either un- 
treated or treated with RA. The cell death in RA-treated cul- 
tures was a consequence of the EtA protein since in indepen- 
dently selected clones of transfected P19 cells, RA-induced 
DNA fragmentation occurred only in those clones that ex- 
pressed the EtA protein (Fig. 2 B). 
Clones of P19 cells expressing different EtA mutants were 
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in RA.  (A) Deletion mutants 
of the 12S E1A cDNA used in 
this  study.  The  protein  en- 
coded  by  the  12S  cDNA  is 
depicted as a bar of  243 amino 
acids  (aa).  The deletion  mu- 
tants encode proteins  with in- 
ternal  deletions:  1101 deletes 
aa 4-25 from the NH2 termi- 
nus,  1104  deletes  aa  48-60 
and  1141 deletes  aa  61-69, 
both affecting the CR1 region, 
and the 1101/1108 double mu- 
tant has deletions  of aa 4-25 
and aa 124-127  altering  both 
the CR1 and CR2 regions of the protein. The ability of each E1A protein to bind p300 and RB is indicated on the right.  (B) Cell numbers 
in cultures  of RA-treated  P19 ('--  -') and P19[1104] (o---o) cultures.  106 cells were seeded into 100-mm culture dishes  in 15 ml of me- 
dium containing 1 #M RA. Cells were harvested after 1, 2, 3, 4, 6, and 8 d and counted with an electronic cell counter.  Each point represents 
the average  from four different  experiments. 
tested in this DNA fragmentation assay. P19 cells expressing 
E1A mutants 1104,  1101, and 1141 all underwent DNA frag- 
mentation  following RA treatment (Fig.  2  C).  These three 
E1A mutants do not bind p300 but do bind members of the 
RB family (18,  32).  The double deletion mutant  1101/1108 
does not bind p300 or members of the RB family. RA-treated 
P19 cells  expressing  the  1101/1108  mutant underwent very 
little DNA fragmentation (Fig. 2 D). These cultures differen- 
tiated like the parental P19 cells into neurons and astrocytes. 
Light and electron microscopy was used to further charac- 
terize  the  dying cells  in  P19[1104]  cultures  (Fig.  3).  Un- 
treated populations of P19 and P19[1104] cells contained few 
or no apoptotic cells (Fig.  3, A and C) but after 3 d  in RA 
up to half of the P19[1104] cell population consisted of cells 
with dark pyknotic nuclei (Fig. 3 D). Ultrastructural exami- 
nation of  these ceils indicated all the expected characteristics 
of cells  undergoing  apoptosis  (Fig.  3  F).  These  included 
clumping of dense chromatin near the nuclear periphery, an 
intact nuclear  membrane,  extensive  cytoplasmic blebbing, 
and intact cytoplasmic organelles.  At later stages apoptotic 
cells showed marked shrinkage and contained small pyknotic 
nuclei. These cultures contained large numbers of cytoplas- 
mic fragments. 
Figure 2.  DNA fragmentation in RA-treated  P19 cells expressing 
E1A proteins.  (A) Kinetics  of DNA fragmentation. DNA was iso- 
lated from P19 cells after 0 (lane 1 ), 3 (lanes 2 and 3), or 4 d (lane 
4) in RA and subjected to gel electrophoresis  and visualization  with 
ethidium  bromide. DNA from P19[1104] cells was isolated  after 0 
(lane 5), 3 (lanes 6 and 7), or 4 d (lane 8) in RA. The cells used 
in lanes 3 and 7were exposed to RA as cell aggregates while other 
cultures were treated  while cells were attached to plastic  surfaces. 
(B) Only E1A-expressing  cells  fragment their DNA in RA.  PI9 
cells were cotransfected with plasmids carrying the puromycin re- 
sistance gene driven by the Pgk-I  promoter and the E1A mutant 
1104 also driven by Pgk-1. Colonies that developed  in puromycin 
were picked and tested  for EIA expression  using  Western  blots 
probed with the M73 antibody.  The same clones were treated  for 
3 d with  RA and their DNAs isolated  and subjected  to gel elec- 
trophoresis.  Lanes I and 9 were from clones of cells expressing  no 
E1A protein while lanes 2-8 were from E1A-expressing cells.  (C) 
E1A proteins with intact CR2 regions induce DNA fragmentation. 
Cells were either untreated  (lanes 1-4) or treated with RA for 3 d 
(lanes  5-10) before  DNA was isolated  and electrophoresed.  P19 
cells are in lanes 1 and 5, P19[l101] in lanes 2 and 6, P19[1104] in 
lanes 3, 7, and 9 and P19[1141] in lanes 4, 8 and 10. (D) EIA protein 
with a deletion  affecting CR2 did not induce DNA fragmentation. 
DNA was  isolated  after 3 d exposure  to RA from P19 (lane  1), 
P19[1101/1108] (lane  2),  and  P19[1104]  (lane  3).  The unlabeled 
lanes in each of A, B, and D contain marker DNA. 
Slack et al. Apoptosis in Neural Differentiation  781 Figure 3. RA-treated P19[1104] cells undergo extensive apoptosis. P19 cells (A and B) and P1911104] cells (C and D) were either untreated 
(A and C) or treated with RA for 3 d (B and D). In toluidene blue stained sections we saw apoptotic nuclei and apoptotic bodies only 
in RA-treated P19[1104] cells (D, arrows). E shows the typical ultrastructural  appearance of P19 cells with multilobulated nuclei and rela- 
tively light chromatin. The cytoplasm contains numerous free ribosomes, few mitochondria and few stacks of rough endoplasmic reticulum. 
F shows an apoptotic cell from an RA-treated P19[1104] culture. This cell has multiple cytoplasmic blebs, dense chromatin clumps along 
the nuclear envelope, and intact cytoplasmic organelles. Bars: (A-D) 10 #m; (E) 2 #m; (F)  1.2 #m. 
Cells Committed to the Neural Lineage 
Undergo Apoptosis 
RA-treated P19 cells differentiate primarily into neurons and 
astrocytes (35, 36) along with some fibroblast-like ceils (54) 
and a few epithelial cells. RA-treated P19 cultures developed 
high levels of neurofilament 160 (NF160) and GFAP, mark- 
ers of neurons and astrocytes respectively (Fig. 4 A). In RA- 
treated P19 cultures, neurons mature within 3 d when NF160 
is detected while astrocytes mature more slowly so GFAP is 
detected only after 8 d.  Surviving cells in RA-treated cul- 
tures of M3, a clone of P19[1104]  cells, contained barely de- 
tectable levels of these two proteins. Similar results were ob- 
tained with P19[l101]  and P19[1141] cells (data not shown). 
The Journal of Cell Biology, Volume  129, 1995  782 Figure 4. E1A-expressing  PI9 cells express few neuronal markers following RA treatment. Cellular protein (A and B) or RNA (C) were 
isolated from cultures at intervals following  exposure to RA. These cells were P19, M3, a clone of P19[1104], and MI8, a clone of P19[1141]. 
The numbers above  each lane represent the number of days in RA. (A) An immunoblot of protein probed with antibodies to the 160-kD 
component of neurofilament (NF160), with antibodies to glial fibrillar acidic protein (GFAP), and with antibodies to actin. Each lane was 
loaded with 50/~g of protein and separated by SDS-polyacrylamide gel electrophoresis before being transferred to nitrocellulose. Immu- 
noreactive material was detected by chemiluminescence. (B) A Northern blot showing  the expression of  the early neuronal marker munc-18. 
RNA was isolated from cultures at the times indicated and 10/~g loaded on each lane before being electrophoresed, blotted, and probed 
with cDNAs for munc-18 and actin. (C) An immunoblot probed with antibodies to cytokeratin 55 (CK55) and actin. Protein preparation 
was similar to that described in A. 
These results suggest that most of the cell death in these cul- 
tures was of cells differentiating into neurons and astrocytes. 
Both  NF160  and  GFAP  are  relatively  late  markers  of 
differentiation while munc-18 (29) is a gene expressed early 
during neuroectodermal differentiation (56). The expression 
of munc-18 was markedly enhanced as P19  cells differen- 
tiated in RA  (Fig.  4  B).  In M3  and M18  cells, clones of 
P19[1104] and P19[1141] cells, respectively, munc-18 mRNA 
levels increased following RA treatment but declined after 
day 3. The loss of munc-18 mRNA from these cultures coin- 
cided with abundant cell death consistent with the idea that 
neural cells were induced and then eliminated from this cell 
population. 
RA-treated P19 cultures normally develop very few epithe- 
lial cells (36, 62).  Cytokeratin 55 is a  protein marker for 
early epithelium and  it is  expressed at  low levels in  RA- 
treated P19 cultures (Fig. 4  C). In contrast, surviving cells 
in RA-treated P19[1104]  cultures contained very high levels 
of cytokeratin 55.  Immunofluorescence with this antibody 
indicated that the majority of P19[1104]  and P19[1141] cells 
surviving  RA  treatment  contained  cytokeratin  filaments 
(data not shown). 
An ultrastructural comparison of P19 and P19[1104]  cells 
7 d after RA treatment was performed. RA-treated P19 cul- 
tures consisted of large numbers of neurons with characteris- 
tic processes (Fig.  5 A).  No such neurons were evident in 
cultures of P19[1104] cells. Many of the surviving P19[1104] 
cells were epithelioid in nature with characteristic intercellu- 
lar junctions (Fig. 5 B). The other cell type evident in these 
P1911104] cultures were large multinucleate cells containing 
cytoplasmic aggregates of intermediate filaments (Fig. 5 C). 
The nature of these aberrant large cells is unknown. 
Gene Expression in RA-treated Cells 
The level of RB expression in P19 cells increases to 10 times 
the level in untreated cells 3-4 d after RA treatment (58). It 
is at this time that extensive cell death occurs in RA-treated 
P19[1104], P19[1141],  and P19[l101]  cells.  In addition, the 
RB-binding domain of E1A is essential for the RA-induced 
apoptosis. These results imply that apoptosis in E1A-express- 
ing P19 cells undergoing differentiation occurs as a result of 
the binding of the mutant E1A protein to proteins of the RB 
family.  We therefore examined the expression of genes be- 
lieved to be targets for regulation by the RB-like proteins. In 
addition,  we  investigated  the  expression of genes  whose 
products mediate and modulate the effects of RB-like proteins. 
The transcription factors E2F and DP-1 are thought to het- 
erodimerize (4, 31) and be negatively regulated by binding 
to  RB  (3,  7,  67).  The  transcripts  of both  are  present  in 
P19, P19[1104], and P19[1141] cells before and during RA- 
induced differentiation (Fig. 6 A). 
The phosphorylation of RB proteins  is  at  least  in  part 
mediated by cyclin-dependent kinases and recent evidence 
suggests a  role for cyclin D-1  in apoptosis (22).  The tran- 
scripts encoding the D cyclins are low in untreated P19 ceils 
and increase following RA treatment (Fig. 6  C).  The level 
of D-1 cyclin appears to be elevated in untreated P19[1104] 
and P19[1141] cells and this level of expression was main- 
tained following exposure to RA.  The level of D-2 cyclin 
mRNA also appeared to be higher in RA-treated cells than 
in the undifferentiated parental cultures while little change 
was  seen in the level of D-3 cyclin mRNA  following RA 
treatment (Fig. 6  C). 
Some immediate early genes are thought to play roles in 
Slack ct al. Apoptosis in Neural Differentiation  783 Figure 5.  Ultrastructure of P19 and P19[1104] cells 7 d after RA treatment.  (A) Electron micrograph  of RA-treated P19 cells with large 
vesicular nuclei, multiple Golgi complexes, a few neurosecretory-like  granules,and neuritic processes with microtubules.  The insert shows 
a number of neuritic processes containing microtubules (curved arrows) along with a single astrocytic process (straight arrow) filled with 
abundant intermediate  filaments.  (B) R.A-treated P19[1104] cultures  contained epithelial  cells with intercellular  junctions (arrows) and 
lateral short interdigitating processes of two opposing cellular  membranes (curved  arrow). (C) RA-treated P19[1104] cultures also contained 
large abnormal cells of undetermined  nature. These cells contained multilobulated  nuclei and focal accumulation  of intermediate filaments 
in the cytoplasm  (arrow). Bars:  (A) 1 #m; (A, inset) 0.3 #m; (B)  1 #m; (C)  1.4 #m. 
The Journal of Cell Biology, Volume 129, 1995  784 Figure 6. Gene expression in differentiating cell cultures. P19, M3 
(P19[1104]) and M18 (PI9[1141]) cells were treated with RA for the 
number of days indicated above each lane. RNA was isolated and 
10/~g run in each lane. Blots were probed for the transcripts indi- 
cated on the right of each panel. The lane marked NR contained 
cells  enriched  for neurons  by culturing  for 8  d  in  serum-free 
medium  (43). (A) Blots were probed with cDNAs for DP-I and 
E2F-1, and each blot was independently probed with actin as a load- 
ing control.  (B) Blots were probed with cDNAs encoding the D 
class of cyclins. (C) The blots were probed with cDNAs encoding 
the transcription  factors c-jun,  c-fos, and c-myc. 
apoptosis (21,  61)  and are known to be modulated during 
RA-induced differentiation of P19 cells (15, 63).  c-jun and 
c-myc  are  induced  following  RA  treatment  of P19  cells 
and expression of both was similarly increased in P19[1104] 
and P19[ll41] cultures (Fig. 6 B). c-fos mRNA levels are very 
low in P19 cells (13) and remain low for many days following 
RA-induced differentiation. In P19[1104]  and P19[1141] cells 
c-fos expression was also low; however, the abundance of the 
c-fos transcript markedly increased after 3--4 d of RA treat- 
ment, the time during which apoptosis became evident in the 
cultures (Fig.  6 B). 
The p53 protein is believed to play a critical role in apop- 
tosis (11, 16, 42, 68). Very high levels of p53 are present in 
untreated P19 and in E1A-expressing P19 cells and these lev- 
els declined markedly after exposure to RA (Fig.  7).  High 
p53 levels are a characteristic of embryonal carcinoma cells 
such  as  P19  and  F9  (41)  and  the  reduced  levels  seen  in 
differentiated cells are similar to those found in fibroblast 
cell cultures. 
ElA-expressing PI9 Cells Fail to Differentiate 
into Mesoderm 
P19 cells are multipotent and aggregates of these cells can 
be induced to differentiate into mesodermal and endodermal 
Slack et al. Apoptosis  in Neural Differentiation  785 Figure 7. Differentiating P19 cells down-regulate p53. Protein from 
cell cultures was subject to SDS-polyacrylamide gel electrophore- 
sis, electroblotted, and probed with antibodies to p53 and to actin. 
Visualization was by chemiluminescence. Lane 1, F9 embryonal 
carcinoma cells; lane 2, P19 cells; lane 3, P19 cells treated for 72 h 
with RA; lane 4, P19[lI01] cells; lane 5, PI9[l101] cells treated 
for 72 h with RA; lane 6, P19[1141] cells; lane 7, P19[1141] cells 
treated for 72 h with RA; lane 8, P19[1101+1108] cells; lane 9, 
P19[1101+1108] cells treated for 72 h with RA. 
cell types. When exposed to 1% DMSO, cardiac muscle is 
formed abundantly from P19 cells. When cultured under the 
same conditions, none of the E1A-expressing P19 cells differ- 
entiated. For example, no muscle was formed in P19[1104] 
cultures treated with 1% DMSO and a marker of undifferen- 
tiated cells, oct-3, was not reduced in abundance (Fig. 8 A). 
RB  expression  is  elevated in  skeletal  muscle  (57)  and 
skeletal muscle is formed from aggregated cultures of P19 
cells exposed to  1.5%  DMSO and  10  -9 M  RA (20).  How- 
ever, none of the E1A-expressing P19 cells exposed to these 
conditions differentiated (Fig.  8 B). 
When aggregated and treated with 1% DMSO, there was 
undetectable cell death in cultures of P19  [1101], P19  [1104], 
and P19[1141]  cells (Fig.  8  C).  The failure of these E1A- 
expressing cells to differentiate means that it is impossible 
to determine if E1A induces apoptosis of cells differentiating 
into mesodermal lineages.  Rather,  it appears that the E1A 
protein interferes with the signal responsible for the initia- 
tion of differentiation into the mesodermal lineages suggest- 
ing that a member of the RB family plays a role in the com- 
mitment of P19 cells to initiate mesodermal development. 
Discussion 
Our results indicate that RB has a crucial role in the differen- 
tiation of cells into neuroectodermal lineages. The levels of 
RB expression in embryos (6) and in differentiating P19 cells 
(58) rise by 10-fold as cells develop into neuroectoderm. In- 
hibiting the function of RB with the E1A protein in differ- 
entiating  P19  cells  resulted in  extensive cell death and  a 
significant decrease in the proportion of surviving cells form- 
ing  neurons  and  astrocytes.  P19  cells  expressing  mutant 
EIA proteins unable to bind RB did not die but differentiated 
normally. The simplest interpretation of this data is that RB 
or other members of the RB family are not only essential for 
the development of neuroectoderm but are also linked to the 
signals leading to programmed cell death in neural ceils. 
The susceptibility of neural tissues to the absence of RB 
during development is consistent with other recent investiga- 
tions. Embryonic mice nullizygous for the Rb gene (10, 34, 
40) show extensive cell death throughout the nervous system 
at the time terminal differentiation was about to take place. 
In transgenic mice expressing HPV-16 E7 (which, like E1A 
binds RB) driven by the interstitial retinol-binding protein 
(IRBP) promoter, photoreceptor cells die at the time when 
they normally undergo terminal differentiation (33). Thus, 
neural cells are predisposed to undergo apoptosis in the ab- 
sence of functional RB. 
A  complex relationship seems to exist between RB and 
p53  and their effects on cell proliferation and death.  The 
apoptosis that occurs in RB deficient mice is dependent on 
p53 (47). On the other hand, undifferentiated embryonal car- 
cinoma cells such as P19 express almost undetectable levels 
of RB along with very high levels of p53,  yet these cells 
proliferate rapidly as  immortal cell lines.  Clearly the ab- 
sence of RB in a p53 containing cell is not sufficient to trig- 
ger apoptosis in all cell types. 
In E1A-expressing PI9 cells we found no normal neurons 
while in RB deficient mice certain subsets of neurons were 
found to differentiate normally. The survival of a subset of 
neurons in RB deficient mice could be due to the expression 
of other members of the RB family in these neurons. The 
E1A proteins expressed in P19 cells are able to bind RB, p107 
and p130, thus affecting the function of the entire family of 
Figure 8. E1A-expressing  PI9 
cells  fail  to  differentiate 
into muscle. (A) P19 (lanes 1 
and 2) and P19[1104] (lanes 3 
and 4) cells were aggregated 
and treated with  1% DMSO. 
On day 0 (lanes I and 3) and 
day 6  (lanes 2 and 4)  RNA 
was  isolated  and  probed  for 
actin and Oct-3. The muscle 
specific  c~-actin  transcripts 
were  expressed  in  DMSO 
treated  P19 cultures (lane 2) 
but  not  in  P19[1104] cells 
(lane  4).  All  cultures  ex- 
pressed  the  larger  B-actin 
mRNA. The Oct-3 transcript is abundant in embryonal carcinoma cells but is reduced in differentiating cultures (lane 2). (B) PI9 (lanes 
1 and 2) and P19[1104] (lanes 3 and 4) were aggregated and treated with 1.5% DMSO and 10  -9 M RA. On day 0 (lanes 2 and 4) and 
day 10 (lanes 1 and 3) RNA was isolated and probed for the skeletal muscle specific marker, myoD, and for tubulin. (C) FI9 (lanes 1 
and 4), P19[1104] (lanes 2 and 5) and P19[1141] (lanes 3 and 6) cells were aggregated and treated for 3 d in RA (lanes 1-3) or 1% DMSO 
(lanes 4-6).  DNA from these cultures was isolated and examined for fragmentation as in Fig. 2. 
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in RB deficient mice perhaps because RB deficient embryos 
die before maturation  of this cell type. Our studies suggest 
that the Rb gene family is not only essential for the differenti- 
ation of neurons, but also their supporting  glial cells. 
Among the surviving cells in RA-treated  cultures of E1A- 
expressing P19 cells,  the reduced development of neurons 
and glia was accompanied by an increased abundance of cells 
expressing  the  epithelial  cell  marker,  cytokeratin  55.  Be- 
cause extensive cell death occurs in these cultures, the abun- 
dance of epithelium may be a consequence of the resistance 
of this cell type to E1A-induced cell death. Alternatively,  the 
EIA protein in differentiating  P19 cells may alter the develop- 
mental program of these cells to favor the formation of epi- 
thelium~ We suspect that both selection and reprogramming 
account for the abundance of epithelium. 
A number of proto-oncogene products  are known to play 
essential  roles in the induction  of apoptosis  and many  of 
these proteins appear  to be present in the RA-treated  P19 
cells. It seems particularly  notable that c-myc and cyclin D1 
are upregulated  during  neuroectodermal differentiation  and 
both are expressed at high levels in E1A-expressing  P19 cells 
when apoptosis is initiated.  On the other hand,  p53 is ex- 
pressed at very high levels in undifferentiated  P19 cells and 
its level declines in RA-treated  cultures. Although the level 
of p53 is low when EIA-expressing P19 cells undergo apop- 
tosis the concentration of p53 protein is nevertheless detect- 
able and similar to that seen in normal cells and tissues. 
The expression of c-fos  is thought  to be a harbinger of 
apoptosis  because c-fos  expression  precedes programmed 
cell death  in vivo (61).  In parental  P19 cells, c-fos mRNA 
levels are very low both before and during differentiation. 
However, in EIA-expressing P19 cells there was a dramatic 
increase in c-fos expression at the time cells undergo apopto- 
sis.  This  increase  in  c-fos  expression  may  be  mediated 
directly or indirecly by the E1A protein. Studies with human 
c-fos  promoter have  identified  a  sequence  motif that  can 
down regulate promoter activity in the presence of RB (51) 
although this sequence is not well conserved in the murine 
promoter. 
RB function appears essential for cells to arrest properly 
in G1 phase when challenged with ionizing radiation  (60). 
The cell death  seen in E1A-expressing P19 cells after RA 
treatment occurs when many of these cells are differentiating 
into neurons and would normally be permanently withdraw- 
ing from the cell cycle. The loss of glia from these cultures 
may be due to the failure of these cells to arrest in G1 before 
maturing.  Alternatively,  the differentiation  of cells into the 
astrocyte lineage may depend on inductive signals from the 
neurons. 
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